Good Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center
|
|
- Deirdre Evans
- 6 years ago
- Views:
Transcription
1 Good Clinical Practice Lisa de Blieck MPA CCRC Clinical Trials Coordination Center
2 Good Clinical Practice (GCP) An international standard for the design, conduct, performance, monitoring, auditing, recording, analyses and reporting of clinical trials Provides public assurance that the data and the reported results are credible and accurate = quality data Ensures the rights, integrity, and confidentiality of subjects are protected = Ethics Quality Data + Ethics = GCPs
3 Compliance in Clinical Research GCP in clinical research refers to compliance with specific regulations and guidelines that govern human medical research Requires adherence to all the trial-related requirements, GCP requirements, and applicable regulatory requirements 3
4 Importance of Compliance Ensures protection of human subjects Meets legal and ethical requirements Protects the integrity of the trial outcome Avoids any compromise of professional integrity 4
5 GCP Guidelines Can t be found in a single document Are based on several regulations and guidances The PPMI study will adhere to ICH, FDA and country-specific regulations Define standards for clinical trial conduct, and Define roles, responsibilities for investigators, sponsors, and IRBs
6 GCP: Shared Responsibility Involves all stakeholders (e.g., IRB, sponsor, investigators) Investigator Responsibilities International Conference on Harmonization (ICH) Guidelines (E6 Good Clinical Practice) 21CFR312 Subpart D 6
7 Principles of GCP per ICH 1. Ethical principles (origin Declaration of Helsinki) 2. Risks, benefits, alternatives must be weighed 3. Rights, safety, and well being of subjects must prevail over interests of the study, science and society 4. The proposed study should be based on sound scientific data 5. ICF prior to initiating trial procedures 6. IRB/IEC approval prior to beginning study 7. Medical care given/medical decisions made by a qualified, licensed physician
8 Principles of GCP per ICH 8. The Investigator is responsible for maintaining a well trained medical research staff 9. Informed consent by subjects must be freely given prior to conducting trial procedures 10. All trial information should be recorded, handled, and stored in a manner permitting its accurate reporting, interpretation and verification 11. Privacy and confidentiality of subject records must be maintained 12. The IP must be appropriately secured, stored and used only per protocol 13. Quality assurance systems must be in place to assure the quality of every aspect of the trial
9 Investigator (per 21 CFR 312.3(a)) qualified by training and experience as the appropriate expert to investigate the study in humans. responsible for the conduct of the clinical trial at a research site is the responsible leader of the team
10 Investigator Responsibilities Adhere to protocol: No changes to research without IRB/IEC approval except to remove immediate hazard Personally conduct and supervise the study, including delegated responsibilities Obtain informed consent prior to initiating trial activities Ensure initial/continuing IRB/IEC review and approval Report all adverse events
11 Investigator Responsibilities Maintain protection of subject and data confidentiality Handle investigational products appropriately Read/understand Investigator s Brochure content, including risks and side effects Prepare and maintain adequate and accurate source information; permit monitoring Promptly report changes in research, unanticipated risks Inform all individuals assisting with study of obligations in meeting these commitments
12 Regulatory Authorities May Ask: Source of study subjects? Did they have the disease under study? Did they meet inclusion/exclusion criteria? Was the protocol precisely followed? Were AEs reported appropriately? What was communicated between investigator and IRB/EC?
13 Formula for Successful Compliance Regulations and responsibilities are defined Learn/understand them Refer to them often Respect them Train on GCP / Practice GCP Follow the protocol Keep accurate records Remember, if it s not documented, it didn t happen! 13
14 Addressing Non-Compliance If findings of non-compliance are communicated, Institute and document corrective actions Retrain as necessary Establish an ongoing re-assessment Carefully review data queries requested Promptly execute follow-up for actions identified during monitoring visits 14
15 GCP References Code of Federal Regulations and ICH Guidelines tml Guidance Documents tore.html Guidance for Industry Investigator Responsibilities Protecting the Rights, Safety, and Welfare of Study Subjects nceregulatoryinformation/guidances/ucm pdf
Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015
18 August 2015 Role & Responsibilities of Principal Dr. R. Sathianathan Professor of Psychiatry, SRMC, Porur & Former Director, Institute of Mental Health, Chennai Principal Investigators & GOOD CLINICAL
More informationOffice of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators
Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators Patricia Fischer, RN, CCRP Investigator Responsibilities FDA Draft Guidance May 2007 Clarifies FDA s expectations,
More informationCLOSE OUT VISIT REPORT (NO CRF TO MONITOR)
Date: Page: 1 of 8 CLOSE OUT VISIT REPORT (NO CRF TO MONITOR) Protocol: PI Name: PI Address: Date of Visit: Monitor(s): Other Sponsor Personnel Present: Site Personnel Present at Visit (include names and
More informationAPEC Preliminary Workshop: Review of Drug Development in Clinical Trials
APEC Preliminary Workshop: Review of Drug Development in Clinical Trials Session 9 B Clinical Trial Assessment Patient Protection Informed Consent Susan D Amico Vice President and Global Head Clinical
More informationFDA Medical Device Regulations vs. ISO 14155
Vol. 11, No. 9, September 2015 Happy Trials to You FDA Medical Device Regulations vs. ISO 14155 By Shawn Kennedy Medical device clinical trials must comply with 21 CFR Parts 11 (Electronic Records), 50
More informationDocumenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC
Documenting the Story of a Clinical Trial: Concept to CAPA Lori T. Gilmartin Gilmartin Consulting LLC The regulations represent the floor while ethical thinking is the sky. Dr. Thomas Moore Boston University
More informationGood Clinical Practice: A Ground Level View
Good Clinical Practice: A Ground Level View Jeanna Julo, BA, BA, CCRP Assistant Director, Clinical Data Management & Quality Controls, Auditing & Training Clinical Research Administration Research Institute,
More informationResearch Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review
Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility
General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and
More informationISO14155: 2011 Clinical investigation of medical devices for human subjects - Good Clinical Practice - ISO TC194 WG4 Madoka Murakami PMDA, Japan
ISO14155: 2011 Clinical investigation of medical devices for human subjects - Good Clinical Practice - ISO TC194 WG4 Madoka Murakami PMDA, Japan What is GCP? Good Clinical Practice (GCP) is an international
More informationStudy Guide for Emergency Care Clinicians. (Version /09/2014)
Study Guide for Emergency Care Clinicians (Version 1.2 26/09/2014) Notes 1. These learning materials are aimed primarily at paramedics, ambulance nurses, emergency care practitioners and doctors recruiting
More informationEssential Documents It s Not Just a Binder!
Essential Documents It s Not Just a Binder! Kelly Unsworth, MS, CCRC, CIP Director of Research Education & Training Office for Human Subject Protection SCORE June 5, 2014 But What percentage of 2014 (to
More informationJoint Statement on the Application of Good Clinical Practice to Training for Researchers
Joint Statement on the Application of Good Clinical Practice to Training for Researchers HRA, MHRA, Devolved Administrations for Northern Ireland, Scotland and Wales v1.1 12/10/17 Summary This joint statement
More informationPublic Input for Changes to Reportable Events Policy
Public Input for Changes to Reportable Events Policy May 23, 2017 Richard Guido, MD, IRB Chair Jamie Zelazny, PhD, RN, Regulatory Affairs Specialist Outline Regulatory basis for reporting policies Importance
More informationInstitutional Review Board Standard Operating Procedures. Education and Training on Human Subject Research Date Last Revised: OVERVIEW
Page 1 of 6 Document Number: IRB-P106 Version Number: 1.3 Institutional Official: David Carlisle, MD, PhD Title: Institutional Review Board Standard Operating Procedures Education and Training on Human
More informationSetting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016
Setting up a CITI account for users not enrolled at or employed by Georgia Tech Georgia Institute of Technology December 2016 www.citiprogam.org Select REGISTER to establish an account. Affiliate with
More informationGood Documentation Practices. Human Subject Research. for
Good Documentation Practices for Human Subject Research Bridget M. Psicihulis, RHIA, CCRC Quality Improvement Unit Coordinator Human Research Protection Program Wheaton Franciscan Healthcare (last updated
More informationEffective Date: April 2014 Revision: September 29, Executive Chair, Co-Chairs, NSHA REB Members, REB Office Personnel, Researchers.
TITLE: Standard Operating Procedure (SOP) External Inspections or Audits NUMBER: NSHA REB-SOP-9-002 Effective Date: April 2014 Revision: September 29, 2017 Applies To: Executive Chair, Co-Chairs, NSHA
More informationCLINICAL RESEARCH POLICY
CLINICAL RESEARCH POLICY Approved by: Date of approval: Originator: Medical Director POLICY STATEMENT Good quality clinical research is important for furthering our understanding of the problems encountered
More informationAuditing of Clinical Trials
Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May
More informationRoles & Responsibilities of Investigator & IRB
Roles & Responsibilities of Investigator & IRB Jaranit Kaewkungwal Mahidol University Regulatory & Guidelines Regulatory & Guidelines GCP & Computer / Database Management Systems International Conference
More informationCourse program. Good Clinical Practice (GCP) course for surgeons
Course program Good Clinical Practice (GCP) course for surgeons 2 Good Clinical Practice (GCP) course for surgeons 7 Principles of Education Based on needs Relevant Interactive Leads to verifiable outcomes
More informationmanaging or activities.
STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This
More informationPROMPTLY REPORTABLE EVENTS
PROMPTLY REPORTABLE EVENTS PURPOSE AND SCOPE To define the structure and responsibility for reporting unanticipated problems that occurs during the conduct of research. APPLICABLE REGULATIONS Policy II.02
More informationAN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES
1 AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES Key Clinical Study Tasks and Activities 2 Discussion of Key Tasks and Activities 3 Development of the Clinical Protocol and Study Materials 3 Qualification
More information12.0 Investigator Responsibilities
12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement, the investigational
More informationToward Greater Scientific Rigor
Toward Greater Scientific Rigor Good Clinical Practice (GCP) A NEW REQUIREMENT! The Center for Clinical & Translational Science 205.934.7442 ccts@uab.edu www.uab.edu/ccts @cctsnetwork The requirement:
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Principles of Data Collection and Storage SOP Number: 8 Supercedes: 1.0 Effective date: August 2013 Review date: August
More information16 STUDY OVERSIGHT Clinical Quality Management Plans
16 STUDY OVERSIGHT... 1 16.1 Clinical Quality Management Plans... 1 16.2 Site Visits by the LOC, SDMC and LC... 2 16.3 Protocol Team Oversight... 3 16.4 Oversight of Reportable Protocol Deviations... 3
More informationA Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky
A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky I. Compliance with IRB and Applicable Federal Requirements A. Investigators
More informationThe GCP Perspective on Study Monitoring
The GCP Perspective on Study Monitoring Heidi Judge, CCRP Sr. Clinical Trials Project Manager Clinical Trials Network and Institute Massachusetts General Hospital 1 Overview Monitoring Basics Who, What,
More informationSTUDY TEAM RESPONSIBILITIES ORIENTATION FOR NEW CLINICAL RESEARCH PERSONNEL MODULE 2
ORIENTATION FOR NEW CLINICAL RESEARCH PERSONNEL MODULE 2 Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network for Research Professionals Overall Agenda for Orientation Module 1: Introduction
More informationIN ACCORDANCE WITH THIS INTERNATIONAL DEVICE STANDARD
COMPLIANCE WITH ISO 14155:2011 GUIDANCE FOR ENSURING YOUR CLINICAL STUDY IS BEING DESIGNED, EXECUTED, AND MONITORED IN ACCORDANCE WITH THIS INTERNATIONAL DEVICE STANDARD Introduction: An increasing trend
More informationUnofficial copy not valid
Page 2 (9) CONTENTS 1. PURPOSE... 3 2. DEFINITIONS... 3 3. RESPONSIBILITY... 3 4. INVESTIGATOR SELECTION... 3 4.1 Identification of Investigator s... 3 4.2 Initial Contacts... 4 4.3 Distribution of Pre-Study
More informationOverview ICH GCP E6(R2) Integrated Addendum
2017 Biomedical Research Alliance of New York LLC CITI Program is a division of BRANY Overview ICH GCP E6(R2) Integrated Addendum Introduction On 15 December 2016, the International Council for Harmonistion
More information*Applicable to: Beaumont Health. Document Type: Policy
Owner: *For This Document, Includes: Beaumont Corporate Shared Services Beaumont Hospital, Dearborn Beaumont Hospital, Farmington Hills Beaumont Hospital, Grosse Pointe Beaumont Hospital, Royal Oak Beaumont
More informationGCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson
GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation
More informationHuman Research Protection Program Institutional Review Board
Human Research Protection Program Institutional Review Board Policies and Procedures Guidebook TABLE OF CONTENTS Federal, State and University Regulations Related to the IRB... Section 1.0 Definition of
More informationHIC Standard Operating Procedure. For-Cause Audits of Human Research Studies
HIC Standard Operating Procedure For-Cause Audits of Human Research Studies Background As part of the Wayne State University (WSU) Human Investigation Committee s (HIC) Human Research Protection Program,
More informationDocument Title: Informed Consent for Research Studies
Document Title: Informed Consent for Research Studies Document Number: SOP003 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationI. Scope This policy defines unanticipated problems and adverse events and establishes the reporting process and timeline.
Human Research Protection Program Policies & Procedures Unanticipated Problems and Adverse Events Version 3.0 Date Effective: 11.9.2012 Research Integrity Office Mail code L106-RI Portland, Oregon 97239-3098
More informationSTUDY INFORMATION POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812)
POST-IRB APPROVAL FDA DEVICE (IDE) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR 812) Purpose: Investigators who initiate and submit an IDE application to the FDA assume the responsibilities of both
More informationInvestigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser
Investigator-Initiated Studies: When you re the Sponsor Cheri Robert & Tammy Mah-Fraser ACRC Clinical Research Conference Edmonton, AB October 15, 2014 Session Objectives Define roles of the investigator,
More informationIRB review of international research. Pre-conference P1 FCPA 3 rd Party Due Diligence for Health Entities. Today
John Heldens, CIP, CCRP Director, UCSF Health Care Compliance Association 2011 Compliance Conference IRB review of international research Pre-conference P1 FCPA 3 rd Party Due Diligence for Health Entities
More informationBIMO SITE AUDIT CHECKLIST
Item AUTHORITY AND ADMINISTRATION FOR STUDIES INVOLVING HUMAN DRUGS, BIOLOGICS AND DEVICES 1. Compare the Investigator Agreement with the information provided by the assigning Center. Auditor will check
More informationDANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:
POLICY #: EDU-100 Page: 1 of 5 1. POLICY STATEMENT: Individuals who participate in research activities overseen by DF/HCC must satisfy specific training requirements in order to conduct human subject research.
More informationUniversity of South Carolina. Unanticipated Problems and Adverse Events Guidelines
University of South Carolina Unanticipated Problems and Adverse Events Guidelines These guidelines define the procedures of USC for addressing unanticipated problems involving risks to research participants
More informationLOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)
LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP) Effective Date: February 7, 2013 SOP Title: Study Monitoring Visits - Process for Access
More informationQUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES
QUALITY TIPS FOR CLINICAL SITES Athena Thomas-Visel Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES Purpose of presentation: Share best practices seen from 150+ sites visited Spark conversation
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationAugust 3, 2017 Clinical Trials at UNC. UNC Symposium for Research Administrators
August 3, 2017 Clinical Trials at UNC UNC Symposium for Research Administrators UNC Symposium for Research Administrators Presenter Christine Nelson, RN, BSN, MBA, CCRC Director, Office of Clinical Trials
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Document Development and Change Control
General Administration GA 104.00 STANDARD OPERATING PROCEDURE FOR Document Development and Change Control Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval:
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationTitle: Investigator Responsibilities. SOP Number: 1501 Effective Date: June 2, 2017
Previous Version Dates: Title: Investigator Responsibilities SOP Number: 1501 Effective Date: June 2, 2017 1 Purpose Investigators are ultimately responsible for the conduct of research. Investigators
More informationOffice of Human Research Office of Human Research Policy and Procedure Manual. Version: 4/4/18
Version: 4/4/18 Signatures on File for the Approval of Revisions to the Policy and Procedures Table of Contents 100 General Administration (GA)... 5 Policy GA 101: The Authority and Purpose of the Institutional
More informationResource Document for IRB members
Resource Document for IRB members The purpose of this document is to provide new members and returning members of the Institutional Review Board (IRB) with: (a) An overview of the roles and responsibilities
More informationETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM
ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM Outline Introduction Composition Responsibilities of IEC Responsibilities
More information(Type inside gray boxes, cells will expand) A. EIGHT POINT CRITERIA for IRB Review
Page 1 of 5 IRB Reviewers 8-Point Analysis Form Based on Federal Policy for the Protection of Human Subjects, Criteria for IRB Approval of Research (45 CFR 46.111) Protocol ID #/Title: Date of Review:
More informationClinical Trial Quality Assurance Common Findings
Clinical Trial Quality Assurance Common Findings Objectives Identify common findings found in research study reviews conducted by the CTQA Program Understand what findings require an action plan vs. a
More informationVertex Investigator-Initiated Studies Program Overview
Vertex Investigator-Initiated Studies Program Overview Our Goal Our Investigator Initiated Study grants support independent, investigator-initiated research designed to advance scientific knowledge of
More informationRisk-Benefit Ratio and Determinations. Sarah Mumford, Ammon Pate, Annie Risenmay IRB Operations Managers University of Utah
Risk-Benefit Ratio and Determinations Sarah Mumford, Ammon Pate, Annie Risenmay IRB Operations Managers University of Utah Risk-Benefit Ratio and Determinations Nuances of Risk Determinations Direct Benefit
More informationStudy Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)
Replaces previous version 203.01: 01 July 2014 Study Start-Up SS 203.01 STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature
More informationUNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD REPORTING UNANTICIPATED PROBLEMS INCLUDING ADVERSE EVENTS
UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD REPORTING UNANTICIPATED PROBLEMS INCLUDING ADVERSE EVENTS I. PURPOSE To specify the procedures for reporting unanticipated problems,
More informationVersion Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13
CONTROLLED DOCUMENT Reporting Research Incidents and Breaches Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the framework and principles for reporting
More informationHuman Research Governance Review Policy
Policy Document Title: Document ID: Document Name: Human Research Governance Review Policy PY-RSH-300304 Human Research Governance Review Policy Version Number: 2 Revision Date: Key Words 28/10/2014 10:40:00
More information3 THE MICROBICIDE TRIALS NETWORK S OPERATIONAL COMPONENTS
3 THE MICROBICIDE TRIALS NETWORK S OPERATIONAL COMPONENTS... 1 3.1 Leadership and Operations Center... 2 3.1.1 LOC Composition... 2 3.1.2 LOC Responsibilities... 3 3.2 Statistical and Data Management Center...
More informationTRAINING NEEDS FOR CPP MEMBERS IN FRANCE
TRAINING NEEDS FOR CPP MEMBERS IN FRANCE Professeur Sylvie Hansel-Esteller EFGCP Bruxelles 30-31/01/2007 Les comités de protection des personnes Long experience since 1988 date of implementation of the
More informationRisk Assessment and Monitoring
Version 1.3 Effective date: 25 May 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.3 25 May 2012 Version 1.2 29 January 2010
More informationInformed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019
Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:
More informationRoles of Investigators in the Managements of Clinical Trials
Roles of Investigators in the Managements of Clinical Trials Chii-Min Hwu, M.D. Section of General Medicine Department of Medicine Taipei Veterans General Hospital Learning Objectives PI Outlines How to
More informationFAQs March 12, 2012 FREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS Table of Contents (Click to follow links) The National Cancer Institute s Central IRB (NCI CIRB)... 2 Standalone HIPAA Authorizations... 3 Retroactive CRADO Waivers... 4 Implementation
More informationTrial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs
R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More informationHow/Where Can we Convey the Notion that Clinical Trials are Relevant for Everyone and Thereby Enhance Delivery of Patient Care?
How/Where Can we Convey the Notion that Clinical Trials are Relevant for Everyone and Thereby Enhance Delivery of Patient Care? Dr. Mei Krishnasamy Executive Director of Cancer Nursing and Allied Health
More informationQuality Assurance and Site Monitoring Visits. Introduction. Training Outline
Instructors: 2009 Web Seminar Series Quality Assurance and Site Monitoring Visits Amanda Moore and Scott Provost, M.M., M.S.W. "This training has been funded in whole or in part with Federal funds from
More informationSTANDARD OPERATING PROCEDURE SOP 325
STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author
More informationSelf-Monitoring Tool
This form is designed for research personnel to use to assess their compliance with TTUHSC El Paso IRB policies and procedures, and federal regulations and guidance governing research with human subjects,
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES WARNING LETTER. (b) (4) clinical investigation (Protocol entitled A Phase II, Multicenter,
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 WARNING LETTER CERTIFIED MAIL RETURN RECEIPT REQUESTED Ronald Bukowski, M.D. 28099 Gates Mills
More informationGrambling State University Application for Human Subjects Review IRB Protocol. 1. Principal Investigator [Last Name, First Name, Middle Initial]
SUBMIT CITI COMPLETION CERTIFICATION WITH FORM 1. Principal Investigator [Last Name, First Name, Middle Initial] Email Phone 2. Department 3. University Status (Check one) a. Faculty b. Staff c. Undergraduate
More information36 th Annual Meeting Preconference Workshop P4 Handout
36 th Annual Meeting Preconference Workshop P4 Handout Clinical Trial Management in Multicenter Trials: Collaborating for Success Meet Our Team Dixie Ecklund, RN, MSN, MBA Associate Director, University
More informationPOINT Trial Organization
3.0 STUDY ORGANIZATION The POINT study is a collaboration of established research networks connected through the leadership of the Principal investigators. Day to day operational oversight is provided
More informationStandard Operating Procedures
Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT
More informationUniversity of Colorado Denver Human Research Protection Program Investigator Responsibilities for the Protection of Human Subjects
Institutional Guidelines The Colorado Multiple Institutional Review Board (COMIRB) recently reviewed and approved your research. The COMIRB reviews research to ensure that the federal regulations for protecting
More information11/18/2016. UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities SESSION 4
UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities BEVERLY ALGER, CCRP, CHRC Research Compliance Officer Office of Research Compliance November 2016
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationNOVA SOUTHEASTERN UNIVERSITY
NOVA SOUTHEASTERN UNIVERSITY DIVISION OF RESPONSIBILITIES FOR RESEARCH AND SPONSORED PROGRAMS Vice President of Research & Technology Transfer: The responsibilities of the Vice President of Research &
More informationBIMO Program Update an operational perspective
BIMO Program Update an operational perspective Clinical Trials Summit San Juan, Puerto Rico May 9, 2018 Anne E. Johnson Program Division Director FDA/ORA/OBIMO Division I (East) 1 Objectives Program Alignment
More informationSOP : Quality Assurance Inspections SCOPE RESPONSIBILITIES. APPROVAL AUTHORITY EFFECTIVE DATE May PURPOSE 2.
TITLE SCOPE RESPONSIBILITIES APPROVAL AUTHORITY EFFECTIVE DATE May 2018 901: Quality Assurance Inspections All research submitted to the University of British Columbia s Research Ethics Boards The Vice
More informationDepartment of Defense Human Research Protection Program DOD INSTITUTIONAL AGREEMENT FOR INSTITUTIONAL REVIEW BOARD (IRB) REVIEW (IAIR)
Department of Defense Human Research Protection Program DOD INSTITUTIONAL AGREEMENT FOR INSTITUTIONAL REVIEW BOARD (IRB) REVIEW (IAIR) General Instructions to Institutions and IRBs This form should be
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationUniversity of Illinois at Chicago Human Subjects Protection Program Plan
Office for the Protection of Research Subjects (OPRS) Institutional Review Board FWA# 00000083 University of Illinois at Chicago Human Subjects Protection Program Plan 203 AOB (MC 672) 1737 West Polk Street
More informationEMORY UNIVERSITY INSTITUTIONAL REVIEW BOARD POLICIES AND PROCEDURES 7/01/2016
EMORY UNIVERSITY INSTITUTIONAL REVIEW BOARD POLICIES AND PROCEDURES 7/01/2016 Emory University 1599 Clifton Road, 5th Floor - Atlanta, Georgia 30322 Tel: 404.712.0720 - Fax: 404.727.1358 - Email: irb@emory.edu
More informationEMA & FDA Inspections: Site perspective. Shandukani Research Centre
EMA & FDA Inspections: Site perspective Shandukani Research Centre Why were we inspected? Pharmaceutical company applied for registration of the study drug (Phase I/II dosing studies in paediatrics) Large
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationPreliminary Questionnaire
Preliminary Questionnaire The purpose of the Preliminary Questionnaire is to assist the REB and the Qualification Team in preparing for the on-site review process. Please complete and sign the Preliminary
More informationBiomedical IRB MS #
Department for Human Research Protections Institutional Review Boards Biomedical IRB MS # 1035 419-383-6796 IRB.Biomed@utoledo.edu Social, Behavioral and Educational IRB MS # 944 419-530-6167 IRB.SBE@utoledo.edu
More informationHuman Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance
Human Subjects Research Policy Update Naomi Coll Director of Research Policy and Compliance Major Policy Updates 1. Continuing review (annual renewal) is no longer required for minimal risk research 2.
More informationVersion 1.1, 6/30/2016 Guidance for Abbreviated IDE Requirements
Version 1.1, 6/30/2016 Guidance for Abbreviated IDE Requirements The Principal Investigator of a study that is requesting an abbreviated IDE for use of a non-significant risk device must attest to the
More informationHonorHealth Research Institute. Investigator Manual. July 27, Version 3.0
HonorHealth Research Institute Investigator Manual July 27, 2017 Version 3.0 VERSION 3.0 JULY 27, 2017 1 Table of Contents Scope... 5 Version History... 5 What is the purpose of this manual?... 5 Abbreviations...
More informationInvestigator Site File Standard Operating Procedure (SOP)
Investigator Site File Standard Operating Procedure (SOP) DOCUMENT CONTROL: Version: 1 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Research Nurse
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures
More information